Searchable abstracts of presentations at key conferences in endocrinology

ea0005p66 | Comparative | BES2003

Sheehan's syndrome and non-functioning pituitary adenoma - a comparison of clinical characteristics and response to growth hormone replacement

Goth M , Auernhammer C , Colak R , Gomez J , Molvalilar S , Kelestimur F

Sheehan's syndrome occurs as a result of ischemic pituitary necrosis due to severe postpartum haemorrhage. It is characterized by varying degrees of anterior pituitary dysfunction and GH is one of the earliest hormones lost. We have compared patients with Sheehan's syndrome (n=189) and with non-functioning pituitary adenoma (NFPA; n=117) to determine whether adult GH deficient patients with Sheehan's syndrome have different baseline characteristics and whether they respond in ...

ea0029p1855 | Thyroid cancer | ICEECE2012

Papillary thyroid carcinoma with a sollitary central nervous system metastasis

Frances Artigas C. , Nicolau Ramis J. , Rivera Irigoin R. , Garcia Bonafe M. , Rodriguez Rodriguez I. , Gil Palmer A. , Olivares Alcolea J. , Gomez Gomez L. , Masmiquel Comas L.

Introduction: Papilar thyroid carcinoma (PTC) is the most common thyroid neoplasia. It usually has a good prognose, being lymph node spread common. Distant metastasis are present in 9–10% of cases, worsening prognose. Cerebral metastasis are extremely rare, representing 1% of all metastasic PTC.Case report: A 68-year-old man was sent to the Endocrinology Unit for follow-up of a PTC that had been operated (total thyroidectomy) 2 months before. After ...

ea0090p389 | Endocrine-related Cancer | ECE2023

Therapeutic potential of the splicing factor SRSF6 as a novel regulator of the Androgen Receptor in prostate cancer

Montero-Hidalgo Antonio J. , Gomez-Gomez Enrique , Saez-Martinez Prudencio , Fuentes-Fayos Antonio C. , Sanchez-Sanchez Rafael , Olmos David , Jesus Martinez-Fuentes Antonio , Sarmento-Cabral Andre , Gahete Manuel D. , Manuel Jimenez Vacas Juan , M Luque Raul

Background: Prostate cancer (PCa) is the fifth leading cause of cancer-related death worldwide. The main pharmacological strategy for this pathology is the blockade of the androgen receptor signalling pathway, commonly known as androgen-deprivation therapy. However, some of the patients does no longer respond to this hormonal therapy. Therefore, finding novel therapeutic strategies to tackle PCa, especially its most advanced phenotype [i.e., castration-resistant prostate cance...

ea0063oc12.3 | Endocrine Connections 2 | ECE2019

Neuronostatin and GPR107 system: a novel therapeutic circuit in prostate cancer

Saez-Martinez Prudencio , Jimenez-Vacas Juan M , Herrero-Aguayo Vicente , Leon-Gonzalez Antonio J , Gomez-Gomez Enrique , Montero-Hidalgo Antonio J , Requena-Tapia Maria J , Castano Justo P , Gahete Manuel D , Luque Raul M

Somatostatin (SST)-system is a pleiotropic hormonal system composed by several ligands/receptors that is involved in the regulation of multiple pathophysiological functions. Specifically, certain components of the SST-system are dysregulated in several endocrine-related cancer types compared to control tissues, wherein these alterations seem to influence their development/progression. However, the presence and functional role of neuronostatin (NST) and its putative G-protein c...

ea0090p383 | Endocrine-related Cancer | ECE2023

MiR-191-5p represents a potential personalized diagnostic and therapeutic tool for PCa patients, especially in obesity conditions

Porcel-Pastrana Francisco , Herrero-Aguayo Vicente , Saez-Martinez Prudencio , M Jimenez-Vacas Juan , Perez Gomez Jesus , Montero-Hidalgo Antonio J. , Carrasco-Valiente Julia , Lopez-Miranda Jose , Anglada Francisco J. , Gomez-Gomez Enrique , Sarmento-Cabral Andre , Gahete Manuel D. , Luque Raul M.

Prostate cancer (PCa) is one of the most common causes of cancer-related deaths in men worldwide. Therefore, more specific non-invasive diagnostic biomarkers with potential therapeutic use are urgently needed. As miRNAs have been proposed as promising elements for the identification of novel diagnostic and therapeutic tools for different pathologies, including different cancer types, we investigated herein the miRNA landscape in PCa patients and explored their putative diagnos...